BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16767382)

  • 1. Neovascularization of the optic disc in Behçet's disease.
    Tugal-Tutkun I; Onal S; Altan-Yaycioglu R; Kir N; Urgancioglu M
    Jpn J Ophthalmol; 2006; 50(3):256-65. PubMed ID: 16767382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal and disc neovascularization in Behçet's disease and efficacy of laser photocoagulation.
    Atmaca LS; Batioğlu F; Idil A
    Graefes Arch Clin Exp Ophthalmol; 1996 Feb; 234(2):94-9. PubMed ID: 8720678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of optic disc neovascularization in patients with Behçet's uveoretinitis after infliximab therapy.
    Kawaguchi T; Sugita S; Yamada Y; Miyanaga M; Mochizuki M
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):627-30. PubMed ID: 21043804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet's disease on infliximab therapy.
    Keino H; Okada AA; Watanabe T; Taki W
    Br J Ophthalmol; 2011 Sep; 95(9):1245-50. PubMed ID: 21183514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of interferon alpha-2a therapy in patients with Behcet's disease.
    Yalçindağ FN; Uzun A
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):439-43. PubMed ID: 22455657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tractional retinal detachment after branch retinal vein occlusion. Influence of disc neovascularization on the outcome of vitreous surgery.
    Ikuno Y; Ikeda T; Sato Y; Tano Y
    Ophthalmology; 1998 Mar; 105(3):417-23. PubMed ID: 9499770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and effectiveness of interferon alpha-2a in treatment of patients with Behçet's uveitis refractory to conventional treatments.
    Sobaci G; Erdem U; Durukan AH; Erdurman C; Bayer A; Köksal S; Karagul S; Bayraktar MZ
    Ophthalmology; 2010 Jul; 117(7):1430-5. PubMed ID: 20417563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.
    Kötter I; Eckstein AK; Stübiger N; Zierhut M
    Br J Ophthalmol; 1998 May; 82(5):488-94. PubMed ID: 9713053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of Behçet's disease in the Indian population.
    Sachdev N; Kapali N; Singh R; Gupta V; Gupta A
    Int Ophthalmol; 2009 Dec; 29(6):495-501. PubMed ID: 18936879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of krypton versus argon scatter photocoagulation for diabetic disc neovascularization. The Krypton Argon Regression Neovascularization Study report number 1.
    Ophthalmology; 1993 Nov; 100(11):1655-64. PubMed ID: 8233391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients.
    Bodaghi B; Gendron G; Wechsler B; Terrada C; Cassoux N; Huong du LT; Lemaitre C; Fradeau C; LeHoang P; Piette JC
    Br J Ophthalmol; 2007 Mar; 91(3):335-9. PubMed ID: 17050581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease.
    Wechsler B; Bodaghi B; Huong DL; Fardeau C; Amoura Z; Cassoux N; Piette JC; LeHoang P
    Ocul Immunol Inflamm; 2000 Dec; 8(4):293-301. PubMed ID: 11262659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with photocoagulation in Behçet's disease.
    Atmaca LS
    Ophthalmic Surg; 1990 Aug; 21(8):571-6. PubMed ID: 2234807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ocular involvement in Behçet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a].
    Deuter CM; Kötter I; Günaydin I; Zierhut M; Stübiger N
    Ophthalmologe; 2004 Feb; 101(2):129-34. PubMed ID: 14991308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neovascularization of the optic disc associated with obstruction of the central retinal artery.
    Duker JS; Brown GC
    Ophthalmology; 1989 Jan; 96(1):87-91. PubMed ID: 2465522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular Manifestations, Conventional Fundus Fluorescein Angiographic Findings, and Relationship Between Angiographic Findings and Visual Acuity in Behçet's Disease.
    Bazvand F; Zarei M; Ebrahimiadib N; Karkhaneh R; Davoudi S; Soleimanzadeh M; Sharifian E; Roohipoor R; Modjtahedi BS
    Semin Ophthalmol; 2017; 32(6):764-771. PubMed ID: 27715380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal tears associated with panuveitis and Behçet's disease.
    Akova YA; Yilmaz G; Aydin P
    Ophthalmic Surg Lasers; 1999; 30(9):762-5. PubMed ID: 10574500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior segment involvement in ocular Behçet's disease.
    Ozdal PC; Ortaç S; Taşkintuna I; Firat E
    Eur J Ophthalmol; 2002; 12(5):424-31. PubMed ID: 12474927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Retinal Neovascularization in Proliferative Diabetic Retinopathy Imaged by Optical Coherence Tomography Angiography.
    Ishibazawa A; Nagaoka T; Yokota H; Takahashi A; Omae T; Song YS; Takahashi T; Yoshida A
    Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6247-6255. PubMed ID: 27849310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indocyanine green and fundus fluorescein angiographic findings in patients with active ocular Behcet's disease.
    Gedik S; Akova Y; Yilmaz G; Bozbeyoğlu S
    Ocul Immunol Inflamm; 2005 Feb; 13(1):51-8. PubMed ID: 15804770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.